| 1 | DNA deamination (GO:0045006) | 6.42044311 |
| 2 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 6.08673471 |
| 3 | cytidine catabolic process (GO:0006216) | 6.08487519 |
| 4 | cytidine deamination (GO:0009972) | 6.08487519 |
| 5 | cytidine metabolic process (GO:0046087) | 6.08487519 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.29207281 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.14896868 |
| 8 | actin nucleation (GO:0045010) | 5.07507369 |
| 9 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.59322954 |
| 10 | monocyte chemotaxis (GO:0002548) | 4.39585115 |
| 11 | proteasome assembly (GO:0043248) | 4.29944412 |
| 12 | negative regulation of T cell apoptotic process (GO:0070233) | 4.28450555 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 4.26617339 |
| 14 | regulation of regulatory T cell differentiation (GO:0045589) | 4.06300718 |
| 15 | protein deneddylation (GO:0000338) | 3.82368908 |
| 16 | protein kinase C signaling (GO:0070528) | 3.80361449 |
| 17 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.79689344 |
| 18 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.79265682 |
| 19 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.77796436 |
| 20 | cullin deneddylation (GO:0010388) | 3.77193678 |
| 21 | positive thymic T cell selection (GO:0045059) | 3.73822249 |
| 22 | platelet dense granule organization (GO:0060155) | 3.67882935 |
| 23 | positive regulation of tolerance induction (GO:0002645) | 3.63744754 |
| 24 | regulation of activation of Janus kinase activity (GO:0010533) | 3.60102761 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.48017342 |
| 26 | positive T cell selection (GO:0043368) | 3.47595191 |
| 27 | B cell mediated immunity (GO:0019724) | 3.45789577 |
| 28 | regulation of T cell tolerance induction (GO:0002664) | 3.44574397 |
| 29 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.43815129 |
| 30 | macrophage chemotaxis (GO:0048246) | 3.42850663 |
| 31 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.42451886 |
| 32 | aggressive behavior (GO:0002118) | 3.41539494 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.38615485 |
| 34 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.35363376 |
| 35 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.35267610 |
| 36 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.34999926 |
| 37 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.32489817 |
| 38 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.32320381 |
| 39 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.32320381 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.29881651 |
| 41 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.27150989 |
| 42 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.20824745 |
| 43 | cytolysis (GO:0019835) | 3.20490361 |
| 44 | deoxyribose phosphate catabolic process (GO:0046386) | 3.15471786 |
| 45 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.14994117 |
| 46 | branched-chain amino acid catabolic process (GO:0009083) | 3.14016286 |
| 47 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.12108027 |
| 48 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.11928171 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.10944078 |
| 50 | regulation of tolerance induction (GO:0002643) | 3.09150304 |
| 51 | rRNA modification (GO:0000154) | 3.06499906 |
| 52 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06438602 |
| 53 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06438602 |
| 54 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06438602 |
| 55 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.06314570 |
| 56 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.06314570 |
| 57 | deoxyribonucleotide catabolic process (GO:0009264) | 3.05618381 |
| 58 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.03415806 |
| 59 | negative regulation of ligase activity (GO:0051352) | 3.03415806 |
| 60 | response to interferon-beta (GO:0035456) | 3.02310848 |
| 61 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.01708768 |
| 62 | hyperosmotic salinity response (GO:0042538) | 3.01423487 |
| 63 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.99254638 |
| 64 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.99254638 |
| 65 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.96321397 |
| 66 | regulation of T cell apoptotic process (GO:0070232) | 2.95832728 |
| 67 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.95561451 |
| 68 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.95561451 |
| 69 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.93402941 |
| 70 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.92725243 |
| 71 | mitochondrial calcium ion transport (GO:0006851) | 2.92341802 |
| 72 | purine-containing compound salvage (GO:0043101) | 2.90537632 |
| 73 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.90391040 |
| 74 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.90190847 |
| 75 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.89844815 |
| 76 | eosinophil chemotaxis (GO:0048245) | 2.89463017 |
| 77 | regulation of B cell differentiation (GO:0045577) | 2.89348206 |
| 78 | regulation of mitochondrial translation (GO:0070129) | 2.87695396 |
| 79 | facial nerve structural organization (GO:0021612) | 2.87583039 |
| 80 | cellular response to interleukin-15 (GO:0071350) | 2.86720585 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84224986 |
| 82 | deoxyribose phosphate metabolic process (GO:0019692) | 2.81468532 |
| 83 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.80356908 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 2.80095801 |
| 85 | regulation of penile erection (GO:0060405) | 2.79633345 |
| 86 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.75897786 |
| 87 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.73334348 |
| 88 | sequestering of actin monomers (GO:0042989) | 2.72892164 |
| 89 | metallo-sulfur cluster assembly (GO:0031163) | 2.71362620 |
| 90 | iron-sulfur cluster assembly (GO:0016226) | 2.71362620 |
| 91 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.69787467 |
| 92 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.68021788 |
| 93 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.67659882 |
| 94 | artery smooth muscle contraction (GO:0014824) | 2.67417674 |
| 95 | negative T cell selection (GO:0043383) | 2.67160061 |
| 96 | ribosomal small subunit assembly (GO:0000028) | 2.66824429 |
| 97 | purine nucleotide salvage (GO:0032261) | 2.65500184 |
| 98 | mast cell degranulation (GO:0043303) | 2.64737706 |
| 99 | mast cell activation involved in immune response (GO:0002279) | 2.64737706 |
| 100 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.63437218 |
LYPLA2P1 
